Clinical Trials
All Clinical Trials - Page 51 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02099084Phase 4Completed
Short Bowel Syndrome and Teduglutide Versus Placebo
Teduglutide
- NCT02125188Phase 4Completed
Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery
Desmopressin
- NCT02043054Phase 3Completed
Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Liraglutide
- NCT02016911Phase 1Completed
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Semaglutide
- NCT01930188Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
Semaglutide
- NCT01885208Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Semaglutide
- NCT01907854Phase 4Completed
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Liraglutide
- NCT02070198Phase 4Unknown
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
Gonadorelin
- NCT02008682Phase 4Completed
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
Liraglutide
- NCT02059564Phase 1Unknown
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Liraglutide
- NCT02020616Phase 1/Phase 2Terminated
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Exenatide
- NCT01910194Phase 2Completed
Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
Lixisenatide
- NCT02020629Phase 4Completed
Study on Lixisenatide and Counterregulation to Hypoglycemia
Lixisenatide
- NCT01886287Phase 2Terminated
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
Octreotide
- NCT02084342N/AUnknown
Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery
Desmopressin
- NCT01982760Phase 2Terminated
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
Desmopressin
- NCT01821846N/ACompleted
Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT01952080Phase 3Completed
A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
Teduglutide
- NCT01982630Phase 1Completed
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
Liraglutide
- NCT01988545N/ACompleted
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Exenatide
- NCT02001363N/AUnknown
Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
Liraglutide
- NCT01761318Phase 4Completed
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Liraglutide
- NCT01836523Phase 3Completed
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Liraglutide
- NCT02308254Phase 1/Phase 2Unknown
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
Lixisenatide
- NCT01960179Phase 3Completed
Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
Lixisenatide
- NCT02166437N/AUnknown
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
Teriparatide
- NCT02217800Phase 2Completed
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
Octreotide
- NCT03771326Phase 3Completed
KP-10 and Insulin Secretion in Men
Kisspeptin
- NCT01940770N/ACompleted
Specific Clinical Experience Investigation for Long-term Use of Bydureon.
Exenatide
- NCT01979341N/AWithdrawn
The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes
Gonadorelin
- NCT01973231Phase 4Completed
Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
Liraglutide
- NCT01954147Phase 1/Phase 2Unknown
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
Liraglutide
- NCT02092597Phase 4Completed
Safety Evaluation of Adverse Reactions in Diabetes
Exenatide
- NCT02571140Phase 1Completed
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Teriparatide
- NCT01952145Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT01942369N/ACompleted
A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months
Gonadorelin
- NCT01931670Phase 3Completed
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Gonadorelin
- NCT01956851N/ACompleted
Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus
Kisspeptin
- NCT01944488N/AUnknown
LH Response to GnRH Test in Prepubescent Girls Under 6 Years
Gonadorelin
- NCT01928329Phase 2Completed
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Exenatide
- NCT01940965Phase 3Completed
Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
Lixisenatide
- NCT01913834Phase 1Unknown
Nasally and sc Administered Teriparatide in Healthy Volunteers
Teriparatide
- NCT02194452N/AWithdrawn
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Octreotide
- NCT01950403Phase 1Completed
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
Linaclotide
- NCT05561647N/ACompleted
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Teduglutide
- NCT01921504N/AUnknown
Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial
Ghrp-6
- NCT02366247Phase 3Unknown
Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B
Thymosin-Alpha-1
- NCT01762943N/ACompleted
Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
Gonadorelin
- NCT01916174Phase 1Completed
A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
Liraglutide
- NCT01890993N/ACompleted
Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
Liraglutide